BamSEC and AlphaSense Join Forces
Learn More

Apellis Pharmaceuticals Inc.

NASDAQ: APLS    
Share price (1/8/25): $33.00    
Market cap (1/8/25): $4.105 billion

Indentures Filter

EX-4.1
from 8-K 14 pages Apellis Pharmaceuticals, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.8
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.7
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.6
from S-3ASR 61 pages Apellis Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.5
from S-3ASR 59 pages Apellis Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.4
from 10-K 2 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 10-K 2 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 10-K 2 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.5
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.4
from S-3ASR 61 pages Apellis Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.3
from S-3ASR 59 pages Apellis Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 8-K 115 pages Apellis Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of September 16, 2019 3.500% Convertible Senior Notes Due 2026
12/34/56
EX-4.6
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.5
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.4
from S-3ASR 61 pages Apellis Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.3
from S-3ASR 59 pages Apellis Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.3
from S-1 7 pages Voting Agreement
12/34/56
EX-4.2
from S-1 67 pages Amended and Restated Investors’ Rights Agreement
12/34/56